Bioventus (BVS) Operating Margin (2020 - 2026)
Bioventus' (BVS) quarterly Operating Margin came in at 6.37% in Q1 2026, up 244.0% YoY from 1.85% in Q1 2025, and down 48.37% on a QoQ basis from 12.34% in Q4 2025.
Bioventus (BVS) Operating Margin (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of Operating Margin data on file, last reported at 6.37% in Q1 2026.
- Quarterly Operating Margin rose 244.0% year-over-year to 6.37% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 9.98% (up 1267.0% YoY) and the FY2025 annual result came in at 9.5%, up 1215.0% from the prior year.
- Operating Margin slipped to 6.37% in Q1 2026, from 12.34% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 12.44% in Q2 2025 to a low of 98.58% in Q4 2022.
- A 5-year average of 9.84% and a median of 2.62% in 2024 frame the typical range for Operating Margin.
- Annual changes were most pronounced in 2022 — Operating Margin slumped 9762 bps — and 2023, when it soared 10058 bps.
- Tracing BVS's Operating Margin over 5 years: stood at 12.43% in 2022, then soared by 107 bps to 0.86% in 2023, then soared by 483 bps to 5.01% in 2024, then jumped by 146 bps to 12.34% in 2025, then plunged by 48 bps to 6.37% in 2026.
- The last three Operating Margin figures came in at 6.37% (Q1 2026), 12.34% (Q4 2025), and 8.12% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 19.15% |
| 10 | Bioventus | 972.56 Mn | 943.11 Mn | 105.67 Mn | 12.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 12.48% |
| Mar 28, 2026 | 6.37% |
| Dec 31, 2025 | 12.34% |
| Sep 27, 2025 | 8.12% |
| Jun 28, 2025 | 12.44% |
| Mar 29, 2025 | 3.93% |
| Dec 31, 2024 | 5.01% |
| Sep 28, 2024 | 2.62% |
| Jun 29, 2024 | -20.81% |
| Mar 30, 2024 | 3.81% |
| Dec 31, 2023 | 0.86% |
| Sep 30, 2023 | 2.00% |
| Jul 1, 2023 | 4.92% |
| Apr 1, 2023 | -77.32% |
| Dec 31, 2022 | -12.43% |
| Oct 1, 2022 | -98.58% |
| Jul 2, 2022 | -2.36% |
| Apr 2, 2022 | -18.29% |
| Dec 31, 2021 | -2.42% |
| Oct 2, 2021 | -0.96% |